These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7008418)
1. Effect of HR (O-(beta-hydroxyethyl)-rutosides) on the impaired venous function of young females taking oral contraceptives. A strain gauge plethysmographic and clinical open controlled study. Forconi S; Guerrini M; Pecchi S; Cappelli R; Bruni F Vasa; 1980; 9(4):324-30. PubMed ID: 7008418 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function. Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872 [TBL] [Abstract][Full Text] [Related]
3. Coagulation studies in women using combination type of oral contraceptives. Sharma S; Sharma M; Soni IJ; Gupta A; Jain R J Obstet Gynaecol India; 1983 Aug; 33(4):519-24. PubMed ID: 12339832 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers]. Stegmann W; Hubner K; Deichmann B; Muller B Phlebologie; 1987; 40(1):149-56. PubMed ID: 3554278 [TBL] [Abstract][Full Text] [Related]
5. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry. Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163 [TBL] [Abstract][Full Text] [Related]
7. [A 3-month, randomized double-blind dose-response study with 0-(beta-hydroxyethyl)-rutoside oral solutions]. Nocker W; Diebschlag W; Lehmacher W Vasa; 1989; 18(3):235-8. PubMed ID: 2678805 [TBL] [Abstract][Full Text] [Related]
8. A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers. Mann RJ Br J Clin Pract; 1981 Feb; 35(2):79-81. PubMed ID: 7020736 [No Abstract] [Full Text] [Related]
9. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study. Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162 [TBL] [Abstract][Full Text] [Related]
10. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency. Bergqvist D; Hallböök T; Lindblad B; Lindhagen A Vasa; 1981; 10(3):253-60. PubMed ID: 7025500 [No Abstract] [Full Text] [Related]
11. Study of the activity of a flavonoid, 3-(beta-hydroxyethyl)-rutoside, at high dose levels on venous tone measured by "strain gauge" plethylsmography. Forconi S; Guerrini M; Di Perri T Vasa; 1977; 6(3):279-84. PubMed ID: 335696 [No Abstract] [Full Text] [Related]
12. [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel]. Gouny AM; Horovitz D; Gouny P; Sauvage E; Nussaume O J Mal Vasc; 1999 Jun; 24(3):214-20. PubMed ID: 10467532 [TBL] [Abstract][Full Text] [Related]
13. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study. Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M Angiology; 2005; 56(1):1-8. PubMed ID: 15678250 [TBL] [Abstract][Full Text] [Related]
14. [Hormonal contraceptives, peripheral venous insufficiency and the use of a phlebodynamic agent]. Cervantes A; Gorodovsky J; Peña A; Campos J Ginecol Obstet Mex; 1976 Aug; 40(238):113-6. PubMed ID: 786800 [No Abstract] [Full Text] [Related]
15. [Dose-response study with O-(beta-hydroxyethyl)-rutoside oral solution]. Nocker W; Diebschlag W Vasa; 1987; 16(4):365-9. PubMed ID: 3321740 [No Abstract] [Full Text] [Related]
16. Coagulation studies in women on combination type of oral contraceptives. Gupta K; Nain S; Manikeri S; Sheth UK; Vaidya P; Mandlekar A; Krishna UR J Obstet Gynaecol India; 1979 Jun; 29(3):647-9. PubMed ID: 12335923 [TBL] [Abstract][Full Text] [Related]
17. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives. Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614 [TBL] [Abstract][Full Text] [Related]
18. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency. Rehn D; Golden G; Nocker W; Diebschlag W; Lehmacher W Arzneimittelforschung; 1993 Oct; 43(10):1060-3. PubMed ID: 8267669 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of O-(beta-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat. Dobyan DC; Bull JM; Strebel FR; Sunderland BA; Bulger RE Lab Invest; 1986 Nov; 55(5):557-63. PubMed ID: 3773477 [TBL] [Abstract][Full Text] [Related]